New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay
Advanced Healthcare Materials · 2023-06 · 12 (14)
DOI: 10.1002/adhm.202201784 ↗At a glance
Journal article in Advanced Healthcare Materials, published online on 2022-11-15. Written by Zhengpeng Wan and 9 co-authors. Institution: Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. Major MEDLINE topics: Microfluidics, Spheroids, Cellular. Cited 89 times so far (Crossref); 90 references. The full text is freely available (open access, CC BY-NC 4.0). Funded by: NCI NIH HHS, National Natural Science Foundation of China, Natural Science Foundation of Guangdong Province.
Abstract (original language)
Previous studies have developed vascularized tumor spheroid models to demonstrate the impact of intravascular flow on tumor progression and treatment. However, these models have not been widely adopted so the vascularization of tumor spheroids in vitro is generally lower than vascularized tumor tissues in vivo. To improve the tumor vascularization level, a new strategy is introduced to form tumor spheroids by adding fibroblasts (FBs) sequentially to a pre‐formed tumor spheroid and demonstrate this method with tumor cell lines from kidney, lung, and ovary cancer. Tumor spheroids made with the new strategy have higher FB densities on the periphery of the tumor spheroid, which tend to enhance vascularization. The vessels close to the tumor spheroid made with this new strategy are more perfusable than the ones made with other methods. Finally, chimeric antigen receptor (CAR) T cells are perfused under continuous flow into vascularized tumor spheroids to demonstrate immunotherapy evaluation using vascularized tumor‐on‐a‐chip model. This new strategy for establishing tumor spheroids leads to increased vascularization in vitro, allowing for the examination of immune, endothelial, stromal, and tumor cell responses under static or flow conditions.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Biological Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
- Department of Mechanical Engineering, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA.
- School of Laboratory Medicine and Biotechnology, Southern Medical University, Guangzhou, Guangdong, 510515, China.
ORCID profiles: Zhengpeng Wan, Roger D Kamm
Funding
- NCI NIH HHS
- National Natural Science Foundation of China
- Natural Science Foundation of Guangdong Province
Cite
APA
Wan, Z., Floryan, M. A., Coughlin, M. F., Zhang, S., Zhong, A. X., Shelton, S. E., Wang, X., Xu, C., Barbie, D. A., & Kamm, R. D. (2023). New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay. Advanced Healthcare Materials, 12(14). https://doi.org/10.1002/adhm.202201784
Vancouver
Wan Z, Floryan MA, Coughlin MF, Zhang S, Zhong AX, Shelton SE, et al. New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay. Advanced Healthcare Materials. 2023;12(14). doi:10.1002/adhm.202201784
BibTeX
@article{Wan2023,
author = {Wan, Zhengpeng and Floryan, Marie A and Coughlin, Mark F and Zhang, Shun and Zhong, Amy X and Shelton, Sarah E and Wang, Xun and Xu, Chenguang and Barbie, David A and Kamm, Roger D},
title = {New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay},
journal = {Advanced Healthcare Materials},
year = {2023},
volume = {12},
number = {14},
doi = {10.1002/adhm.202201784}
}
EUVIMED